Our Partnerships
CureMetrix is a global leader in Artificial Intelligence for medical imaging, committed to advancing technology that improves healthcare and survival rates across the globe. Its mission is to help save lives with early and more accurate detection and support improved clinical and financial outcomes, delivering technology that radiologists, healthcare systems, and patients can rely on with confidence.
In partnership with Medicom Technologies Inc., Onsite has created a platform to elevate the patient and clinician journey through advancements in medical image exchange.
Our partnership with Myriad Genetics brings Myriad’s hereditary breast cancer/risk assessment resources, MyRisk with RiskScore, into Onsite provider practices where younger patients can be screened more readily. Women determined to be at an increased risk are advised about the guidelines for screening at younger ages.
Our partnership with Volpara Analytics helps Onsite improve and sustain quality through consistent, fair and unbiased assessment of positioning and overall mammographic images. Using Volpara Analytics artificial intelligence (AI) software, each Onsite mammogram image is reviewed for appropriate positioning, compression and radiation dose.